Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharmacology > Antidiabetic drugs > Flashcards

Antidiabetic drugs Flashcards

1
Q

What are the two groups of D.M?

A

type 1: insulin dependent D.M

type 2: non-insulin dependent D.M

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

describe Type 1 D.M…

A

deficiency of insulin.
- autoimmune attack of beta cells of the pancreas -> gradual depletion of beta cell population -> sx’s appear when 80-90% destroyed -> pancreas fails to respond to ingestion of glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is expected in glucose-induced insulin release test for normal subjects, type 1 D.M, and type 2 D.M?

A

normal subjects: see a huge rise of plasma insulin when infused of glucose.
Type 1 D.M: see no rise of plasma insulin.
Type 2 D.M: see a slow rise of plasma insulin but below normal subjects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the characteristics of type 1 D.M?

A
  • elevated blood glucose and ketone bodies.
  • virtually no insulin secretion
  • rely on exogenous insulin injxn SC to control hyperglycemia and avoid ketoacidosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the characteristics of type 2 D.M?

A
  • most common
  • combination of insulin resistance and dysfunction beta cells.
  • insulin levels may be high, esp early in the disease. but peripheral insulin resistance and increased liver production of glucose make insulin levels inadequate to normalize plasma glucose levels.
  • insulin production then falls -> no longer compensate for insulin resistance, hyperglycemia develops.
  • metabolic alterations are milder than type 1 D.M
  • insulin secretion is enough to restrain ketogenesis.
  • HYPERGLYCEMIA but NO KETOACIDOSIS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

describe insulin…

A
  • small protein

- 2 polypeptide chains connected by disulfide bonds.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

describe insulin secretion…

A
  • released from beta cells at a low basal rate and much higher rate in response to a variety of stimuli.
  • stimulated by: glucose, amino acids and GI hormones (incretins)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the incretin effect?

A

glucose given orally results in higher insulin levels than glucose given IV. This is b/c incretins, released by the gut, enhance insulin secretion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the mechanism of insulin secretion in beta cells?

A

Glucose enters via GLUT transporter -> increased glycolysis and citric acid cycle -> elevated ATP -> closes Katp channel -> less K leaves cell -> cell depolarizes -> Ca channel opens -> Ca entry triggers exocytosis and insulin is secreted.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

describe insulin receptor…

A
  • two covalently linked heterodimers.
  • each contains an alpha subunit and a beta subunit.
  • alpha = extracellular and recognition site for insulin.
  • beta = spans the membrane and contains a tyrosine kinase.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how is insulin receptor activated?

A
  • insulin binds to alpha subunit, the tyrosine kinase is activated in the beta subunit -> phosphorylation of tyrosine residues on beta subunit and the cytoplasmic proteins.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the effects of insulin on its targets?

A
  1. glucose entry in muscle and adipose tissue via GLUT4.
  2. glycogen synthesis in liver and muscle.
  3. F.A synthesis and storage as TAG in adipose tissue
  4. glycolysis
  5. A.A uptake by muscle
  6. inhibit gluconeogenesis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the sources of insulin?

A
  1. isolated insulin from beef or pork pancreas.

2. recombinant DNA technology using strains of E.coli or yeast.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the different types of insulin preparations?

A
  1. rapid-acting: fast onset and short duration
  2. short-acting: rapid onset of action
  3. intermediate-acting.
  4. long-acting: slow onset of action
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the rapid-acting insulins?

A
  1. insulin Lispro
  2. insulin Aspart
  3. insulin Glulisine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
  1. insulin Lispro
  2. insulin Aspart
  3. insulin Glulisine

chemistry?

A
  • native insulin monomers are associated as hexamers

- problem: slow the absorption of insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Insulin Lispro

chemical differences compared to insulin B-chain?

A

28th position: Pro replaced by Lys

29th position: Lys replaced by Pro

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Insulin Aspart

chemical differences compared to insulin B-chain?

A

28th position: Pro replaced by Asp

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Insulin Glulisine

chemical differences compared to insulin B-chain?

A

3rd position: Asp replaced by Lys

29th position: Lys replaced by Glu

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q
  1. insulin Lispro
  2. insulin Aspart
  3. insulin Glulisine

PD and PK?

A
  • mimic the prandial release of insulin.
  • given along c a longer acting insulin to assure proper glucose control.
  • SC, IV
  • give 15mins before a meal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Short-acting insulins

PD and PK?

A
  • regular insulin
  • soluble crystallin zinc insulin
  • given 30mins before a meal
  • SC, IV in emergencies.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what is the intermediate-acting insulins?

A

Neutral protamine Hagedorn (NPH) - aka isophane insulin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Neutral protamine Hagedorn (NPH) - aka isophane insulin

PD and PK?

A
  • suspension of crystalline zince insulin combined c protamine.
  • SC
  • used for basal control.
  • given along c rapid- or short-acting insulin for mealtime control.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what are the long-acting insulins?

A
  1. Insulin Glargine

2. Insulin Detemir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Insulin Glargine

Chemical difference compared to insulin A-chain?

A

21st position: Asn replaced by Gly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Insulin glargine

Chemical difference compared to insulin B-chain?

A

extra Arg-Arg at the end.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

How does Insulin glargine get into the Blood?

A

injxn of an acidic sln (pH 4) -> precipitate in SC tissue -> slow dissolution of free glargine hexamers -> dimers -> monomers -> dimers and monomers can enter capillary membrane -> blood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Insulin Detemir

Chemical difference compared to insulin B-chain?

A

29th position: Lys with additional N-C=O-R chain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What is the difference between insulin analogs vs human insulin preparations?

A

regimens based on rapid- and long-acting insulin analogs improve HbA1c levels and reduce hypoglycemia compared c regimens c regular insulin and NPH insulin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What are some ways of insulin administrations?

A
  1. syringe
  2. insulin pen
  3. insulin pump
  4. IV
  5. inhaled
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

when is best to use IV insulin?

A
  • pts c ketoacidosis, during perioperative period, during labor and delivery, and in Intensive Care situations.
  • use regular human insulin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Inhaled insulin

PD and PK?

A
  • dry powder formulation or regular human insulin
  • for adults c type 1 and 2 D.M
  • peak levels reached in 12-15mins and decline to baseline in 3 hrs.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Inhaled Insulin

A.E and contraindications?

A
  • cough, throat pain, hypoglycemia
  • pulmonary function should be monitored.
  • pts c asthma, COPD, and smokers.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

what is the insulin secretion pattern in the pancreas?

A

secretes boluses of insulin in response to meals.

b/w meals and throughout the night, secretes small amounts to suppress lipolysis and liver glucose output.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

what are the two methods to achieve a similar insulin secretion pattern?

A
  1. Basal-Bolus insulin regimens

2. insulin pump therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Basal-Bolus Insulin regimens

uses?

A
  • long-acting insulin can be given at bedtime or in the morning.
  • if pt skips a meal, omit a premeal bolus.
  • if eat a larger meal than usual, increase the premeal bolus.
  • dose adjustments can be made to accommodate snacks, exercise patterns, and acute illnesses.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Insulin pump therapy

uses?

A
  • mimic normal insulin secretion

- battery-operated pump and a computer that programs the pump to deliver predetermined amounts of insulin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

What are the insulins used in insulin pump?

A
  1. glulisine
  2. lispro
  3. aspart
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

what are the A.E of using insulin therapy?

A
  1. hypoglycemia (when overdose)
    higher risk in regular insulin than rapid-acting.
    higher risk in NPH insulin than long-acting.
  2. Allergic rxns (often d/t noninsulin protein contaminants)
  3. Lipodystrophy at injxn sites
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

How to manage hypoglycemia from insulin overdose?

A

mild case: orange juice, glucose or any sugar-containing bev or food.

severe case (unconsciousness or stupor): IV glucose infusion.

glucagon SC or IM if IV not avail.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

What are some of the drug interactions that cause hypoglycemia?

A
  1. Ethanol
  2. Beta blockers
  3. salicylates
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

How does EtOH cause hypoglycemia w/ insulin therpay?

A

inhibits gluconeogenesis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

How does beta blockers cause hypoglycemia w/ insulin therpay?

A

blocking the effects of catecholamines on gluconeogenesis and glycogenolysis.

also mask the sympathetically-mediated sx’s of hypoglycemia (i.e tremor and palpitations).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

How does salicyclates cause hypoglycemia w/ insulin therpay?

A

enhancing pancreatic beta cell sensitivity to glucose and potentiating insulin secretion.

weak insulin like action in the periphery.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

What are some of the drug interactions that cause hyperglycemia by acting on peripheral tissues that counter the actions of insulin?

A
  1. epi
  2. glucocorticoids
  3. atypical antipsychotics
  4. HIV protease inhibitors.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

What are some of the drug interactions that cause hyperglycemia by inhibiting insulin secretion directly?

A
  1. phenytoin
  2. clonidine
  3. Ca- channel blockers.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

What are some of the drug interactions that cause hyperglycemia by inhibiting insulin secretion indirectly?

A

Diuretics via depletion of K.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

What is the management of Diabetes in Hospitalized pts?

A

d/c oral anti-diabetics and replaced c insulin.

oral agents can be restarted on discharge.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

what are some of the non-insulin antidiabetic agents?

A
  1. Insulin secretagogues: sulfonylureas & Meglitinides
  2. Biguanides
  3. Thiazolidinediones (TZDs)
  4. alpha- glucosidase inhibitors
  5. incretin analogs
  6. inhibitors of DPP-IV
  7. amylin analogs
  8. bile-acid sequestrants
  9. SGLT2 inhibitors.
50
Q

What are two insulin secretagogues?

A
  1. Sulfonylureas

2. Meglitinides

51
Q

sulfonylureas

MOA?

A

stimulate insulin release from beta cells

binds to SUR1 subunit and block ATP-sensitive K channel in cell membrane

52
Q

What are the two first generation sulfonylureas?

A

Tolbutamide

Chlorpropamide

53
Q

Tolbutamide

PK and A.E?

A

short duration of action

Prolonged hypoglycemia occurs rarely

54
Q

Chlorpropamide

PK and A.E?

A
  • long half life
  • hypoglycemia = contraindicated in elderly pts.
  • hyperemic flush c EtOH d/t inhibition of aldehyde dehydrogenase.
  • potentiate action of vasopressin -> elicit SIADH.
55
Q

What are the three second generation sulfonylureas?

A
  1. glyburide (glibenclamide)
  2. Glipizide
  3. Glimepiride
56
Q
  1. glyburide (glibenclamide)
  2. Glipizide
  3. Glimepiride

PK and A.E?

A
  • more potent than first gen.
  • lack some a.e and drug interactions of first gen. - hypoglycemia
  • weight gain.
57
Q

Glyburide

A.E?

A

hypoglycemia 20-30%

58
Q

Glipizide

PK and A.E?

A

shortest half life of the more potent agents

Less hypoglycemia

59
Q

Glimepiride

A.E?

A

hypoglycemia 2-4%

approved for once-daily use.

60
Q

what are the two meglitinides?

A
  1. repaglinide

2. nateglinide

61
Q

Meglitinides MOA?

A

stimulate insulin release by binding to SUR1 and inhibiting ATP-sensitive K channel.

not as effective as sulfonylureas in reducing FPG and HbA1c levels.

62
Q
  1. repaglinide
  2. nateglinide

PK and PD?

A
  • rapid onset and short duration of action
  • postprandial glucose regulators
  • rapidly absorbed and cleared.
  • taken before each meal, if meal is missed the drug must be omitted.
63
Q
  1. repaglinide
  2. nateglinide

A.E?

A

Hypoglycemia - repaglinide
less hypoglycemia - nateglinide
weight gain - both

no sulfur = good for pts c sulfur or sulfonylurea allergy

64
Q

what is one biguanides and its features?

A

Metformin

  • cause insulin secretion
  • does not cause hypoglycemia, even in large doses
  • equivalent to sulfonylureas in reducing FPG and HbA1c levels.
65
Q

Metformin

MOA?

A
  • inhibiting gluconeogenesis by reducing gene expression of gluconeogenic enzymes
  • increases insulin mediated glucose utilization in muscle and liver.
  • activation of AMP-activated protein kinase (AMPK)
66
Q

Metformin

Indications?

A
  • FIRST LINE AGENT in type 2 DM

- use alone or in combo c sulfonylureas, TZDs and/or insulin.

67
Q

Metformin

A.E?

A
  • GI: anorexia, nausea, vomiting, abd discomfort, diarrhea
  • interfere c B12 absorption
  • lactic acidosis
68
Q

Metformin

contraindications?

A
  • renal disease
  • hepatic disease
  • hypoxia
  • alcoholism
69
Q

What are the two Thiazolidinediones (TZDs)?

A
  1. Pioglitazone

2. Rosiglitazone

70
Q
  1. Pioglitazone
  2. Rosiglitazone

MOA?

A
  • decrease insulin resistance.
  • agonists of peroxisome proliferator-activated recpetor gamma (PPAR-gamma) - intracellular receptor in muscle, fat, and liver.
  • promote glucose uptake and utilization in adipose tissue.
  • less effective in decreasing FPG and HbAc1 compared to sulfonylureas and metformin
  • mechanism involves gene regulation
  • slow onset and offset of activity over weeks or even months.
71
Q

how is pioglitazone better than rosiglitazone in the effects of lipids?

A 
sig improvement in:
HDL
TG
LDL particle concentration
LDL particle size
72
Q
  1. Pioglitazone
  2. Rosiglitazone

A.E?

A
  • fluid retention
  • weight gain
  • edema
  • exacerbation CHF - contra in Class III and IV HF.
  • must monitor liver function
73
Q

what are the two alpha-glucosidase inhibitors?

A
  1. acarbose

2. miglitol

74
Q
  1. acarbose
  2. miglitol

MOA?

A

inhibit intestinal alpha-glucosidases -> reduce postprandial digestion of starch and disaccharides -> decrease hyperglycemia and hyperinsulinemia -> modest drop in HbAc1 and FPG.

75
Q
  1. acarbose
  2. miglitol

A.E?

A
  • flatulence
  • diarrhea
  • abd pain
76
Q
  1. acarbose
  2. miglitol

contraindications?

A
  • IBS

- intestinal condition worsened by gas and distension

77
Q

what is acarbose associated with?

A

reversible hepatic enzyme elevation

required liver funct monitoring.

78
Q

define diabetes mellitus…

A

elevation of fasting blood glucose caused by a relative or absolute deficiency in insulin.

79
Q

what is an encretin analog?

A

Exenatide

80
Q

describe Exenatide…

A
  • analog of GLP-1
  • derived from salivary gland of the Gila monster
  • injectable
  • full agonist at human GLP-1 receptor
  • resistant to dipeptidyl peptidase IV (DPP-IV)
81
Q

exenatide

action of beta cells?

A

glucose in gut lumen stimulates incretin secretion -> enhance glucose-stimulated insulin secretion in beta cells.

82
Q

exenatide

MOA?

A
  • enhances glucose-dependent insulin secretion.
  • suppresses postprandial glucagon release
  • slows gastric emptying
  • decrease appetite
  • may stimulate beta-cell proliferation
83
Q

exenatide

clinical applications?

A

type 2 D.M in adults

84
Q

exenatide

A.E?

A
  • nausea, vomiting, and diarrhea

- acute pancreatitis

85
Q

exenatide

contraindications?

A

pts c gastroparesis

86
Q

Name the inhibitor of DDP-IV?

A

Sitagliptin

87
Q

Sitagliptin

MOA?

A
  • selective inhibitor of DPP-IV

- increases circulating GLP-1 and insulin levels.

88
Q

sitagliptin

clinical applications?

A

type 2 d.m in adults.

89
Q

sitagliptin

A.E?

A
  • pancreatitis
  • hypersensitivity rxns:
    urticaria
    angioedema
    anaphylaxis
    Stevens-Johnson syndrome
90
Q

name the amylin analog?

A

pramlintide

91
Q

pramlintide

MOA?

A
  • inhibits food intake
  • gastric emptying
  • glucagon secretion
92
Q

what is amylin?

A

co-secreted c insulin from pancreatic beta-cells.

93
Q

pramlintide

clinical uses?

A

adjunctive to insulin

94
Q

Name a bile-acid sequestrants?

A

colesevelam

95
Q

colesevelam

MOA?

A

lower LDL cholesterol

mechanism is unclear

96
Q

colesevelam

clinical applications?

A

type 2 DM

97
Q

Name a SGLT2 inhibitor?

A

Canagliflozin

98
Q

What action is SGLT2?

A

reabsorption of glucose in the proximal tubule of the kidney.

99
Q

Canagliflozin

MOA?

A
  • blocks SGLT2 -> decreased glucose reabsorption, increase execretion -> decrease blood glucose
100
Q

Canagliflozin

A.E?

A
  • Genital and urinary tract infxns
  • osmotic diuresis -> vol depletion, increased serum creatinine levels, hyperkalemia, hypermagnesemia, hyperphosphatemia, hypotension
101
Q

anagliflozin

contraindications?

A

pts c GFR

102
Q

What is the preferred monotherapy for Type 2 D.M?

A

Metformin

103
Q

What is best therapy for HbA1c >9%?

A

combination of two non-insulin agents or c insulin itself.

104
Q

What happens if monotherapy does not achieve HbA1c goal over 3mos?

A

add a second agent (Dual combo therapy)

- oral agent, exenatide, or insulin

105
Q

What is the next step if the two-drug combo fails?

A

add a third agent (triple combo therapy)

- insulin most likely

106
Q

describe the transition to insulin therapy?

A
  • begun at a low dose c a single injxn of basal insulin.
    • either NPH, glargine, or detemir
  • then dose is uptitrated.
107
Q

What is the step if significant postprandial glucose excursions occur?

A

add prandial insulin therapy c shorter-acting insulins.

– lispro, aspart, or glulisine.

108
Q

When is insulin be warranted as initial therapy in type 2 DM?

A
  1. sig hyperglycemia sx’s
  2. ketonuria
  3. HbA1c >10%
  4. random glucose >300mg/dL
109
Q

How to manage HTN in diabetes complications?

A

ACE inhibitor or an ARB.

110
Q

How to manage dyslipidemia in diabetes complications?

A

Statins given regardless of lipid level.
given:
1. c overt CVD
2. s CVD who are >40y.o and c one or more other CVD risk factors.
(fam hx, HTN, smoking, dyslipidemia, or albuminuria)

111
Q

How to manage coagulation in diabetes complications?

A

aspirin

112
Q

How to manage nephropathy in diabetes complications?

A

ACE inhibitors or ARBs when pts have albuminuria.

113
Q

How to manage neuropathic pain in diabetes complications?

A
  1. amitriptyline
  2. pregabalin
  3. gabapentin
  4. duloxetine
  5. venlafaxine
  6. valproate
  7. opioids
114
Q

How to manage gastroparesis in diabetes complications?

A

metoclopramide or erythromycin

115
Q

How to manage erectile dysfunction in diabetes complications?

A

phosphodiesterase type 5 inhibitors

116
Q

How to manage foot infxns in diabetes complications?

A

common = staph

emperic abs therapy target gram+ cocci.

117
Q

what is the DOC to tx pregnant females c D.M?

A

regular insulin

118
Q

describe glucagon…

A

peptide hormone synthesized by pancreatic alpha cells.

119
Q

what are the functions of glucagon?

A 
(+):
glycogen degradation
gluconeogenesis
fatty acid oxidation
insulin release
cardiac inotropy & chronotropy
relaxation of the intestine (in large doses)

(-): glycolysis

120
Q

glucagon

uses?

A
  1. severe hypoglycemia
  2. radiology of the bowel
  3. beta blocker poisoning
  4. glucagon C-peptide test

Pharmacology (13 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions